Education

KUBTEC® is Now the Only Company Offering a 17x17 inch (43 x 43 cm) Detector in the Pathology Market
As of March 18, 2025, HOLOGIC® has officially discontinued sales of the Faxitron® Path+ Specimen Radiography System. KUBTEC® is now the only company in the Pathology market offering a 17x17 inch (43x43 cm) detector available with our XPERT® 80-L System.

KUBTEC® Celebrates 20 Years of Medical & Scientific Technology Innovation
This week marks a major milestone for KUBTEC®, as the company celebrates its 20th anniversary of delivering advanced X-ray cabinet systems that have transformed both clinical care and scientific research around the world.

Beaumont Hospital in Dublin Deploys MOZART® 3D Specimen Imaging System
We are proud to share that Beaumont Hospital in Dublin is now equipped with the MOZART® 3D Specimen Imaging System.

Why Specimen Radiography Matters in the Gross Room
In the fast-paced environment of a gross room, accuracy and efficiency are paramount. Every tissue sample processed plays a crucial role in patient care, so proper and timely specimen evaluation from the outset can significantly impact diagnostic accuracy and treatment decisions. This is where specimen radiography steps in, providing real-time imaging to support Pathologists' Assistants (PAs), Pathology Residents, and Pathologists in their daily workflow.

3D Specimen Tomosynthesis Real-Time Assessment by Radiologists and Surgeons Potentially Decreases the Margin Re-excision Rate Following Breast-Conserving Surgery
The intra-operative use of the 3D specimen tomosynthesis function could potentially save 20-50% of patients from a second operation. This would lead to a significant improvement in patient outcomes and a reduction in the cost of healthcare provision.
.jpg)
Sentinel Lymph Node Biopsy in Cancer Treatment
Sentinel lymph node biopsy (SLNB) is an increasingly valuable procedure in cancer care, particularly for melanoma and breast cancer. By isolating and testing sentinel lymph nodes—the first nodes that harbor cancer cells once they exit from a primary tumor—SLNB allows doctors to determine whether the cancer has spread while avoiding extensive invasive surgery.